SCHEMBL22200929

SCHEMBL22200929

CC(=O)N[C@@H]1CCc2c(C)c(F)cc(N)c2C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.42
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
BRD3 Q15059 1/20 0.34
CRBN Q96SW2 3/20 0.33
TOP2A P11388 1/20 0.33
TOP2B Q02880 1/20 0.33
CYP11B2 P19099 5/20 0.32
CYP11B1 P15538 3/20 0.32
CYP2C9 P11712 2/20 0.31
TSHR P16473 2/20 0.31
MITF O75030 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL37106799 1.00 LMNA (0.42) LMNAKDM4EPOLBMAPTCA12
SCHEMBL7165490 1.00 LMNA (0.42) LMNAKDM4EPOLBMAPTCA12
SCHEMBL26623041 0.93 BRD3 (0.42) LMNAKDM4EPOLBMAPTBRD3
SCHEMBL24728401 0.89 LMNA (0.43) LMNAKDM4EPOLBMAPTCA12
SCHEMBL30138591 0.89 LMNA (0.43) LMNAKDM4EPOLBMAPTCA12
SCHEMBL26471064 0.88 KDM4E (0.36) LMNAKDM4EPOLBMAPTCRBN
SCHEMBL30841804 0.88 KDM4E (0.42) LMNAKDM4EPOLBMAPTCA12
SCHEMBL30221837 0.87 BRD3 (0.31) LMNAKDM4EPOLBMAPTBRD3
SCHEMBL30221744 0.87 BRD3 (0.31) LMNAKDM4EPOLBMAPTBRD3
SCHEMBL26623051 0.87 BRD3 (0.31) LMNAKDM4EPOLBMAPTBRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3677568-A1 NOVEL METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE DAIICHI SANKYO COMPANY, LIMITED (JP) 2020-07-08 EP disclosed